[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337250-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337250-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","kif2cmcak-a-prognostic-biomarker-and-its-oncogenic-potential-in-malignant-progression-and-prognosis-of-cancer-patients-a-systematic-review-and-meta-analysis","KIF2C/MCAK a Prognostic Biomarker and Its Oncogenic Potential in Malignant Progression, and Prognosis of Cancer Patients - a Systematic Review and Meta-analysis","","KIF2C/MCAK (KIF2C) is the most well-characterized kinesin-13 family member governing microtubule dynamics during mitosis and interphase. This systematic review summarizes KIF2C structural elements, regulation through multiple molecular mechanisms, and broad cellular functions. It consolidates evidence on KIF2C’s oncogenic potential in malignant progression and quantifies its prognostic value in cancer patients. KIF2C is linked to cell migration and invasion, DNA repair, senescence induction, and immune modulation, correlating with multiple hallmarks of cancer and consistent poor prognosis in meta-analyses.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/kif2cmcak-a-prognostic-biomarker-and-its-oncogenic-potential-in-malignant-progression-and-prognosis-of-cancer-patients-a-systematic-review-and-meta-analysis/337250/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/kif2cmcak-a-prognostic-biomarker-and-its-oncogenic-potential-in-malignant-progression-and-prognosis-of-cancer-patients-a-systematic-review-and-meta-analysis/337250.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does KIF2C/MCAK play in cancer biology?","Question",{"text":63,"@type":64},"KIF2C is a kinesin-13 family member regulating microtubule dynamics during mitosis and interphase. The review links KIF2C to processes such as cell migration and invasion, DNA repair, senescence induction, and immune modulation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the review assess KIF2C as a prognostic biomarker?",{"text":68,"@type":64},"The work performs a systematic search and pools available data into weighted meta-analyses. Outcomes include correlations between KIF2C high expression and overall survival and disease-free survival across cancer entities.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the meta-analyses indicate about cancer prognosis with high KIF2C expression?",{"text":72,"@type":64},"All meta-analyses reported poor prognosis associated with KIF2C high expression, including decreased overall survival and reduced disease-free survival. This supports KIF2C’s oncogenic potential in malignant progression and its value as a prognostic marker.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337250,1790196900,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":55,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Author Manuscript Author Manuscript Author Manuscript Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Crit Rev Clin Lab Sci. Author manuscript; available in PMC 2025 February 12. |\n| --- | --- |\n\nPublished in final edited form as:  \nCrit Rev Clin Lab Sci. 2024 September ; 61(6): 404–434. doi:10.1080/10408363.2024.2309933 .  \nKIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker  \nNina-Naomi Kreisa,* , Ha Hyung Moona,* , Linda Wordemanb, Frank Louwena, Christine Solbacha, Juping Yuana, Andreas Rittera  \naObstetrics and Prenatal Medicine, Gynaecology and Obstetrics, University Hospital Frankfurt, J.  \nW. Goethe-University, Frankfurt, Germany  \nb Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA, USA  \nAbstract  \nKIF2C/MCAK (KIF2C) is the most well-characterized member of the kinesin-13 family,  \nwhich is critical in the regulation of microtubule (MT) dynamics during mitosis, as well as interphase. This systematic review briefly describes the important structural elements of KIF2C, its regulation by multiple molecular mechanisms, and its broad cellular functions.  \nFurthermore, it systematically summarizes its oncogenic potential in malignant progression and performs a meta-analysis of its prognostic value in cancer patients. KIF2C was shown to be involved in multiple crucial cellular processes including cell migration and invasion, DNA repair, senescence induction and immune modulation, which are all known to be critical during the development of malignant tumors. Indeed, an increasing number of publications indicate that KIF2C is aberrantly expressed in multiple cancer entities. Consequently, we have highlightedits involvement in at least five hallmarks of cancer, namely: genome instability, resisting cell death, activating invasion and metastasis, avoiding immune destruction and cellular senescence.  \nThis was followed by a systematic search ofKIF2C/MCAK’s expression in various malignant tumor entities and its correlation with clinicopathologic features. Available data were pooled into multiple weighted meta-analyses for the correlation between KIF2Chigh protein or gene  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ([http://creativecommons.org/](http://creativecommons.org/)[ ](http://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.  \nCONTACT Andreas Ritter, [aRitter@em.uni-frankfurt.de](aRitter@em.uni-frankfurt.de), Obstetrics and Prenatal Medicine, Gynaecology and Obstetrics, University spitalontribFurantedfuqul,lJy.. W. Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany.  \nAuthors’ contributions  \nNNK, AR, and HM conceived the manuscript. AR designed the search strategy. AR, NNK and HM performed the article screening and data extraction. AR and NNK wrote the initial manuscript. JY and HM modified the manuscript. CS, FL and JY did critical reading. All authors read and approved the final manuscript.  \nSupplemental data for this article can be accessed online at [https://doi.org/10.1080/10408363.2024.2309933](https://doi.org/10.1080/10408363.2024.2309933) .  \nThis article was originally published with errors, which have now been corrected in the online version. Please see Correction ([http://](http://)[ ](http://)[dx.doi.org/10.1080/10408363.2024.2327873](dx.doi.org/10.1080/10408363.2024.2327873)).  \nDisclosure statement  \nNo potential conflict of interest was reported by the author(s) .  \nAuthor Manuscript Author Manuscript Author Manuscript Author Manuscript  \nKreis et al. Page 2  \nexpre","cbCaik83bcXWJaxi","https://ap.wps.com/l/cbCaik83bcXWJaxi","pdf",1608656,52,"English","# Abstract\n# Keywords\n# 1. Background\n## Microtubule dynamics and mitotic regulation","[{\"question\":\"What role does KIF2C/MCAK play in cancer biology?\",\"answer\":\"KIF2C is a kinesin-13 family member regulating microtubule dynamics during mitosis and interphase. The review links KIF2C to processes such as cell migration and invasion, DNA repair, senescence induction, and immune modulation.\"},{\"question\":\"How does the review assess KIF2C as a prognostic biomarker?\",\"answer\":\"The work performs a systematic search and pools available data into weighted meta-analyses. Outcomes include correlations between KIF2C high expression and overall survival and disease-free survival across cancer entities.\"},{\"question\":\"What do the meta-analyses indicate about cancer prognosis with high KIF2C expression?\",\"answer\":\"All meta-analyses reported poor prognosis associated with KIF2C high expression, including decreased overall survival and reduced disease-free survival. This supports KIF2C’s oncogenic potential in malignant progression and its value as a prognostic marker.\"}]","KIF2C/MCAK a Prognostic Biomarker and Its Oncogenic Potential in Malignant Progression, and Prognosis of Cancer Patients - a Systematic Review and Meta-analysis | PDF",1790018334,131,[147,151,155,159,163,167],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47ba0047d635d1b34104ca25a915dfed.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27b1e256e13a5cf2fbc3ae197e8e145c.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eac0e638d1f9aa4d5ef6663fe088f696.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d335ef2c443e61accae1129542328642.webp",980,1268,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/975c16dc5a1724b89c7d6641b3a13fa2.webp",979,1267,{"page_no":55,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f68a30877455aaa5c65df44934fe5c5.webp",978,1265]